SGLT2 Inhibitors in Heart Failure

SGLT2 inhibitors are a class of medications which were initially approved to lower blood glucose levels in patients with diabetes. Then it was discovered that these medications could also improve outcomes for patients with heart failure, regardless of whether they had diabetes or not. So sad that cost should impact what we choose as first line evidence-based medical therapy for these patients? I totally agree. And actually, I suspect that we are going to be working on this in our heart failure advocacy group to advocate for equal access to care.